Meyer Andrew Hollman 4
4 · Janux Therapeutics, Inc. · Filed Apr 23, 2025
Insider Transaction Report
Form 4
Meyer Andrew Hollman
Chief Business Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2025-04-21−3,334→ 90,665 totalExercise: $4.21Exp: 2031-03-09→ Common Stock (3,334 underlying) - Exercise/Conversion
Common Stock
2025-04-21$4.21/sh+3,334$14,036→ 85,473 total - Sale
Common Stock
2025-04-21$30.00/sh−3,334$100,020→ 82,139 total
Footnotes (2)
- [F1]The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024.
- [F2]Immediately exercisable.